Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
BioProcess Internation...BioProcess International US West
Not Confirmed
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Not Confirmed
Not Confirmed
09-11 March, 2026
Not Confirmed
Not Confirmed
09-11 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
BioProcess Internation...BioProcess International US West
Industry Trade Show
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
09-11 March, 2026
Industry Trade Show
Not Confirmed
09-11 March, 2026
Digital content

03 Feb 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/insilico-medicine-receives-usd-5million-milestone-payment-from-menarini-group-following-first-in-human-fih-achievement-for-men2501-302676790.html

22 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/menarini-silicon-biosystems-announces-pace-trial-biomarker-analysis-results-confirming-clinical-utility-of-cellsearch-ctc-enumeration-to-guide-treatment-decisions-in-a-specific-metastatic-breast-cancer-subtype-302647277.html

09 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/menarini-group-presents-elacestrant-orserdu-phase-2-combination-data-in-patients-with-er-her2--metastatic-breast-cancer-mbc-at-the-2025-san-antonio-breast-cancer-symposium-302635656.html

24 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/the-volpi-rosse-menarini-the-fantastic-ten-are-ready-for-the-2025---2026-season-302624579.html

24 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/menarini-group-announces-new-data-on-elzonris-tagraxofusp-erzs-to-be-presented-at-the-67th-american-society-of-hematology-annual-meeting-and-exposition-302624638.html

02 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/menarini-groups-obicetrapib-and-obicetrapibezetimibe-marketing-authorisation-applications-accepted-for-review-by-the-european-medicines-agency-ema-for-the-treatment-of-adults-with-primary-hypercholesterolaemia-heterozygous-fa-302543737.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE